Pharmagreen Biotech Inc. (PHBI)
Pharmagreen Biotech Inc. is a biotechnology solutions provider primarily engaged in cultivating young plant stock for the medical cannabis and CBD hemp industries. Established in 2007, the company operates from its base in Coquitlam, Canada.
Sector: Airports, Flying Fields & Airport Terminal Services
Industry: Drug Manufacturers - Specialty & Generic
Pharmagreen Biotech Inc.
OTC:PHBIHealthcare · Drug Manufacturers - Specialty & Generic
Mkt Cap$115K
Float313K
O/S346K
Inst Own-
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$2K
Net Income$406K
Total Assets$8K
Free Cash Flow-$23K
Debt & Equity
Total Debt$356K
Total Equity-$2.63M
Preferred Stock$10
Shares Outstanding
Short Interest
Split History2 splits · 1 reverse
2-year cumulative
1:2,000Over cap
Past the 1:250 Nasdaq cap, ineligible for a bid-price compliance period
- 1:2,000Reverse splitAug 12, 20262,000 shares → 1
- 10:1Forward splitMar 10, 20091 share → 10
Balance Sheet Details
Assets$8K
Liabilities$2.69M
Accounts Receivable$602
Accounts Payable$893K
Inventory$6K
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 | 2009-04-30 | 2008-04-30 |
| Revenue | $2K | $3K | $3K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | -30.0% | 13.7% | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $3K | $2K | $9K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | -$400 | $2K | -$6K | $0 | -$435K | -$435K | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | -16.8% | 50.9% | -215.0% | - | - | - | - | - | - | - | - |
| Research and Development | $0 | $0 | $0 | $0 | $0 | $0 | $4K | $8K | $0 | $0 | $0 |
| Selling, General, and Administrative | $290K | $250K | $468K | $1.07M | $753K | $486K | $648K | $662K | $19K | $70K | $2K |
| Other | $0 | $0 | $0 | $252 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $290K | $250K | $468K | $1.07M | $753K | $486K | $652K | $670K | $19K | $70K | $2K |
| Operating Income (EBIT) | -$290K | -$248K | -$474K | -$1.07M | -$753K | -$677K | -$648K | -$670K | -$19K | -$70K | -$2K |
| Operating Margin | -12164.7% | -7272.7% | -15810.5% | - | - | - | - | - | - | - | - |
| Interest Expense | $42K | $33K | $121K | $47K | $769K | $627K | $123K | $4K | $0 | $0 | $0 |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $78K | $0 | $0 |
| Other Income (Expense) | $697K | -$756K | -$95K | $194K | -$3.78M | -$2M | -$120K | -$404K | $4 | $0 | $0 |
| Income Before Tax (EBT) | $406K | -$1M | -$569K | -$876K | -$4.53M | -$2.48M | -$769K | -$1.07M | -$19K | -$70K | -$2K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $842K | $122K | $0 | $0 | $0 | $0 |
| Net Income | $406K | -$1M | -$569K | -$875K | -$4.53M | -$2.44M | -$768K | -$1.07M | -$19K | -$70K | -$2K |
| Net Income Margin | 17016.9% | -29442.8% | -18979.3% | - | - | - | - | - | - | - | - |
| Supplementary Data | |||||||||||
| EPS | 0.60 | -3.00 | -2.40 | -4.40 | -30.80 | -60.00 | -24.00 | -86.60 | -134.20 | -520.00 | -0.03 |
| Diluted EPS | 0.60 | -3.00 | -2.40 | -4.40 | -30.80 | -60.00 | -24.00 | -86.60 | -134.20 | -520.00 | -0.03 |
| Weighted Average OS | 331,823 | 329,685 | 233,266 | 201,867 | 146,854 | 41,036 | 37,031 | 12,405 | 8,109 | 134 | 49,153 |
| EBITDA | -$290K | $182 | $26K | $242K | -$3.01M | -$1.32M | $6K | -$400K | $0 | -$70K | -$2K |
| EBITDA Margin | -12164.7% | 5.3% | 867.5% | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 | 2009-04-30 | 2008-04-30 |
| Assets | |||||||||||
| Current Assets | |||||||||||
| Cash and Cash Equivalents | $721 | $276 | $1K | $8K | $25K | $12K | $63K | $152K | $21 | $0 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $721 | $276 | $1K | $8K | $25K | $12K | $63K | $152K | $21 | $0 | $0 |
| Accounts Receivable | $602 | $585 | $608 | $383 | $290 | $295 | $11K | $32K | $3K | $0 | $0 |
| Inventory | $6K | $8K | $9K | $0 | $0 | -$295 | -$11K | $0 | -$400K | $0 | $0 |
| Other Current Assets | $0 | $0 | $22K | $0 | $0 | $295 | $126K | $0 | $397 | $0 | $0 |
| Total Current Assets | $8K | $9K | $33K | $209K | $373K | $266K | $189K | $198K | $21 | $0 | $0 |
| Long-Term Assets | |||||||||||
| Property, Plant & Equipment Net | $0 | $0 | $0 | $0 | $0 | $435K | $441K | $251K | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $89K | $89K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | $0 | $0 | $0 | -$441K | $0 | $4K | $0 | $0 |
| Total Long-Term Assets | $0 | $89K | $89K | $0 | $0 | $435K | $441K | $251K | $4K | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | -$435K | $0 | $0 | -$0 | $0 | $0 |
| Total Assets | $8K | $98K | $122K | $209K | $373K | $266K | $630K | $449K | $4K | $0 | $0 |
| Liabilities | |||||||||||
| Current Liabilities | |||||||||||
| Accounts Payable | $893K | $800K | $739K | $645K | $580K | $455K | $830K | $590K | $0 | $9K | $200 |
| Short-Term Debt | $356K | $266K | $282K | $219K | $231K | $681K | $75K | $0 | $1.54M | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $744K | $650K | $501K | $34K | -$2.26M | $0 | $0 |
| Other Current Liabilities | $1K | $1M | $1.19M | $326K | -$1.21M | $788K | $57K | $929K | $64K | $0 | $0 |
| Total Current Liabilities | $3K | $3.14M | $2.21M | $1.91M | $2.03M | $3.17M | $1.46M | $1.84M | $64K | $9K | $200 |
| Long-Term Liabilities | |||||||||||
| Long-Term Debt | $0 | $91K | $91K | $119K | $39K | $33K | $2K | $693 | $15K | $3K | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $12K | $0 | $788 |
| Total Long-Term Liabilities | $0 | $91K | $91K | $119K | $39K | $33K | $2K | $693 | $27K | $3K | $788 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2.69M | $3.23M | $2.3M | $2.03M | $2.07M | $3.2M | $1.46M | $1.84M | $91K | $11K | $988 |
| Stockholders' Equity | |||||||||||
| Preferred Stock | $10 | $10 | $10 | $10 | $10 | $0 | $0 | $0 | $7K | $0 | $0 |
| Common Stock | $664K | $664K | $573K | $442K | $381K | $96K | $76K | $72K | $57K | $54K | $5K |
| Retained Earnings | -$13.74M | -$14.15M | -$13.14M | -$12.57M | -$11.7M | -$7.17M | -$4.73M | -$3.96M | -$185K | -$71K | -$32K |
| Comprehensive Income & Other | $127K | $77K | $76K | $94K | -$8K | $37K | $48K | $39K | -$63K | $0 | $0 |
| Other Stockholders' Equity | $10.45M | $10.4M | $10.44M | $10.36M | $9.67M | $4.18M | $3.82M | $2.5M | $41K | $6K | $26K |
| Total Equity | -$2.63M | -$3.09M | -$2.13M | -$1.78M | -$1.65M | -$2.89M | -$833K | -$1.39M | -$87K | -$11K | -$988 |
| Minority Interest | -$47K | -$47K | -$47K | -$47K | -$47K | -$47K | -$1K | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $54K | $144K | $168K | $256K | $420K | $313K | $632K | $449K | $4K | $0 | $0 |
| Supplementary Data | |||||||||||
| Total Debt | $356K | $356K | $373K | $339K | $270K | $715K | $77K | $693 | $15K | $3K | $0 |
| Net Debt | $355K | $356K | $372K | $331K | $245K | $702K | $14K | -$151K | $15K | $3K | $0 |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 | 2009-04-30 | 2008-04-30 |
| Operating Activities | |||||||||||
| Net Income | $406K | -$1M | -$569K | -$876K | -$4.53M | -$2.44M | -$769K | -$1.07M | -$19K | -$70K | -$2K |
| Depreciation & Amortization | $0 | $248K | $474K | $1.07M | $753K | $486K | $648K | $670K | $592K | $0 | $0 |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $0 | $0 | $76K | $461K | $628K | $11K | $173K | $0 | $0 | $0 | $0 |
| Changes in Working Capital: | |||||||||||
| Accounts Receivable | -$17 | $23 | -$225 | -$93 | $5 | $10K | $21K | -$29K | -$2K | $0 | $0 |
| Inventory | $2K | $804 | -$9K | $0 | -$5 | -$10K | -$21K | $0 | $0 | $0 | $0 |
| Accounts Payable | $94K | $0 | $0 | $65K | $148K | -$16K | $231K | $18K | $0 | $9K | $0 |
| Other Working Capital | $94K | $123K | $220K | $177K | -$237K | -$47K | -$76K | -$55K | -$2K | -$9K | $30K |
| Total Working Capital Change | $190K | $124K | $211K | $243K | -$90K | -$63K | $156K | -$37K | -$2K | $9K | $30K |
| Other Non-Cash Items | -$620K | $604K | -$267K | -$1.32M | $3.04M | $1.4M | -$525K | -$345K | -$592K | -$9K | -$30K |
| Net Cash from Operating | -$23K | -$28K | -$74K | -$427K | -$206K | -$608K | -$318K | -$786K | -$21K | -$61K | -$2K |
| Investing Activities | |||||||||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 | $0 | -$196K | -$251K | -$4K | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | -$196K | $0 | -$900 | $0 | $0 |
| Net Cash from Investing | $0 | $0 | $0 | $0 | $0 | $0 | -$196K | -$251K | -$4K | $0 | $0 |
| Financing Activities | |||||||||||
| Debt Repaid | -$29K | -$29K | -$83K | -$127K | $10K | -$528K | -$263K | -$194K | -$14K | -$2K | -$788 |
| Common Stock Issuance | $0 | $0 | $0 | $187K | $268K | $40K | $390 | $0 | $12K | $29K | $32K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $0 | $0 | $0 | -$5K | $170K | $929K | $12K | $0 | $0 |
| Net Cash from Financing | $29K | $29K | $83K | $314K | $257K | $563K | $433K | $1.12M | $39K | $30K | $32K |
| Forex Effect | -$5K | -$1K | -$16K | $96K | -$38K | -$5K | -$8K | $50K | -$82K | $0 | $0 |
| Net Change in Cash | $445 | -$978 | -$7K | -$17K | $13K | -$50K | -$89K | $135K | $11 | -$31K | $31K |
| Supplementary Data | |||||||||||
| Operating Cash Flow | -$23K | -$28K | -$74K | -$427K | -$206K | -$608K | -$318K | -$786K | -$21K | -$61K | -$2K |
| Capital Expenditure | $4 | -$4 | $0 | $0 | $0 | $0 | -$196K | -$251K | -$4K | $0 | $0 |
| Free Cash Flow | -$23K | -$28K | -$74K | -$427K | -$206K | -$608K | -$514K | -$1.04M | -$25K | -$61K | -$2K |
| Cash at Beginning | $276 | $1K | $8K | $25K | $12K | $63K | $152K | $16K | $10 | $31K | $0 |
| Cash at End | $721 | $276 | $1K | $8K | $25K | $12K | $63K | $152K | $21 | $0 | $31K |